School of Medicine


Showing 11-20 of 62 Results

  • Imelda Balboni

    Imelda Balboni

    Clinical Associate Professor, Pediatrics - Rheumatology

    Current Research and Scholarly InterestsPediatric systemic lupus erythematosus;
    Autoimmune disease;
    Proteomics and autoantigen microarray technology

  • Yair Bannett

    Yair Bannett

    Instructor, Pediatrics

    Current Research and Scholarly InterestsDr. Bannett seeks to use data-driven methods to develop reliable quality measures for management of children with developmental and behavioral (DB) conditions in community-based primary care. Current observational studies use multi-level analysis of electronic health record data and clinician interviews. Dr. Bannett plans to use natural language processing to accurately assess quality of care, with the ultimate goal of improving health care delivery for children with DB conditions.

  • Donald Barr

    Donald Barr

    Professor (Teaching) of Pediatrics (General Pediatrics), Emeritus

    BioDonald Barr is a Professor of Pediatrics in the Stanford School of Medicine, and Professor by Courtesy in the Graduate School of Education. He teaches in the Undergraduate Program in Human Biology, where he helped to found Human Biology's curriculum in health policy. His research has studied the effect of the organizational structure of the U.S. medical care delivery system on the quality of primary care. He has also studied cultural and linguistic barriers to health care access for low-income patients, and factors associated with higher rates of attrition from pre-medical studies among minority students at Stanford and other universities. The fourth edition of his book, Introduction to U.S. Health Policy: The Organization, Financing, and Delivery of Health Care in America, was published in 2016. The third edition of his book, Health Disparities in the United States: Social Class, Race, Ethnicity and the Social Determinants of Health, was published in 2019. In June 2003 Dr. Barr was awarded the Lloyd W. Dinkelspiel Award for Distinctive Contribution to Undergraduate Education at Stanford University. In 2006 he received the Miriam Aaron Roland Prize, which recognizes Stanford faculty who engage and involve students in integrating academic scholarship with significant and meaningful volunteer service to society.

  • Dorsey Bass

    Dorsey Bass

    Associate Professor of Pediatrics (Gastroenterology), Emeritus

    Current Research and Scholarly InterestsOur laboratory is interested in the pathophysiology, immunology, and epidemiology of viral gastroenteritis.

  • Hannah Bassett

    Hannah Bassett

    Clinical Associate Professor, Pediatrics

    Current Research and Scholarly InterestsUnderstanding how to implement real time patient-centered healthcare cost transparency in the acute care setting and how this transparency effects patient and system-level outcomes.

    Understanding how to best decrease unnecessary variation in clinical care through implementation of clinical effectiveness tools.

  • Glaivy Batsuli, MD

    Glaivy Batsuli, MD

    Assistant Professor of Pediatrics (Hematology/Oncology)

    Current Research and Scholarly InterestsHemophilia is a rare inherited X-linked bleeding disorder characterized by the deficiency of blood clotting proteins factor VIII or factor IX. These individuals are at risk for spontaneous bleeds and trauma or surgery-induced bleeding. There have been remarkable advancements in the management of hemophilia to prevent these bleeding episodes and improve quality of life. However, the presence of neutralizing antibodies, called inhibitors, still dictates access to novel therapies such as factor replacement for bleed management and now FDA-approved gene therapies. The Batsuli Lab is focused on elucidating mechanisms of the immune response to blood coagulation proteins in bleeding disorders in order to develop strategies and therapeutics for inhibitor prevention and tolerance induction.

    Dr. Batsuli's clinical research interests also include clinical trial participation for novel therapeutics & interventions in bleeding disorders such as hemophilia and von Willebrand disease in addition to coagulation issues & outcomes in ultra-rare bleeding disorders and sickle cell disease.